Published in Clin Infect Dis on October 01, 1999
Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J Gastroenterol (2012) 2.21
The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29
Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis (2008) 1.23
Medical treatment versus "Watch and Wait" in the clinical management of CE3b echinococcal cysts of the liver. BMC Infect Dis (2014) 0.92
Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay. Parasitol Res (2005) 0.89
Cystic echinococcosis of the liver: A primer for hepatologists. World J Hepatol (2014) 0.87
Management of serology negative human hepatic hydatidosis (caused by Echinococcus granulosus) in a young woman from Bangladesh in a resource-rich setting: A case report. IDCases (2014) 0.84
Treatment of liver hydatidosis: how to treat an asymptomatic carrier? World J Gastroenterol (2010) 0.83
Current status of diagnosis and treatment of hepatic echinococcosis. World J Hepatol (2016) 0.81
Genome-wide sequencing of small RNAs reveals a tissue-specific loss of conserved microRNA families in Echinococcus granulosus. BMC Genomics (2014) 0.81
Transcriptome profiles of the protoscoleces of Echinococcus granulosus reveal that excretory-secretory products are essential to metabolic adaptation. PLoS Negl Trop Dis (2014) 0.78
Human hydatid disease in Peru is basically restricted to Echinococcus granulosus genotype G1. Am J Trop Med Hyg (2008) 0.76
Cloning and characterization of an Echinococcus granulosus ecdysteroid hormone nuclear receptor HR3-like gene. Parasite (2017) 0.75
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
The functional organization of the nopaline A. tumefaciens plasmid pTiC58. Plasmid (1980) 6.22
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Cyclospora species--a new protozoan pathogen of humans. N Engl J Med (1993) 4.56
Community infection ratio as an indicator for tuberculosis control. Lancet (1995) 3.53
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg (1978) 3.06
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Transfer of RP4::mu plasmids to Agrobacterium tumefaciens. Plasmid (1978) 2.77
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 2.26
Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol (1998) 2.17
A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr (1999) 2.05
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Interactions and DNA transfer between Agrobacterium tumefaciens, the Ti-plasmid and the plant host. Proc R Soc Lond B Biol Sci (1979) 1.89
Fecal contamination of shanty town toddlers in households with non-corralled poultry, Lima, Peru. Am J Public Health (1990) 1.89
Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88
A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86
Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am J Epidemiol (1997) 1.82
Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol (2000) 1.77
The role of non-biting flies in the epidemiology of human infectious diseases. Microbes Infect (2001) 1.74
Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA (1991) 1.69
Hyperendemic pulmonary tuberculosis in a Peruvian shantytown. Am J Epidemiol (1998) 1.67
A new coccidian parasite (Apicomplexa: Eimeriidae) from humans. J Parasitol (1994) 1.65
Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63
Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63
Prevalence and prediction of hypoxemia in children with respiratory infections in the Peruvian Andes. J Pediatr (1991) 1.62
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62
Helicobacter pylori populations in Peruvian patients. Clin Infect Dis (1997) 1.57
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg (1992) 1.53
Isolation of Cryptosporidium parvum and Cyclospora cayetanensis from vegetables collected in markets of an endemic region in Peru. Am J Trop Med Hyg (1997) 1.53
Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52
Gallstone disease in high-altitude Peruvian rural populations. Am J Gastroenterol (1999) 1.51
Pulmonary tuberculosis in children in a developing country. Pediatrics (2001) 1.50
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Pulse wave velocity and coronary risk stratification. Rev Port Cardiol (2009) 1.44
Epidemiology and treatment of Cyclospora cayetanensis infection in Peruvian children. Clin Infect Dis (1997) 1.43
Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis (2011) 1.43
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41
Immunoblot (western blot) and double diffusion (DD5) tests for hydatid disease cross-react with sera from patients with cysticercosis. Trans R Soc Trop Med Hyg (1992) 1.41
Cholera incidence and El Niño-related higher ambient temperature. JAMA (2000) 1.40
Detection of Mycobacterium tuberculosis in nasopharyngeal aspirate samples in children. Lancet (1998) 1.39
Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J Infect Dis (1999) 1.38
Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis (1997) 1.38
Carbon monoxide trend, meteorology, and three-way catalysts in Mexico City. J Air Waste Manag Assoc (1998) 1.38
An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis (2000) 1.37
Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg (1996) 1.37
Efficacy of a live oral cholera vaccine in human volunteers. Dev Biol Stand (1976) 1.37
Identification of gallbladder typhoid carriers by a string device. Lancet (1979) 1.36
Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg (1999) 1.36
Risk factors for burns in children: crowding, poverty, and poor maternal education. Inj Prev (2002) 1.34
Differentiating Taenia solium and Taenia saginata infections by simple hematoxylin-eosin staining and PCR-restriction enzyme analysis. J Clin Microbiol (2000) 1.34
Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg (1998) 1.33
Spontaneous formation of cointegrates of the oncogenic Ti-plasmid and the wide-host-range P-plasmid RP4. Plasmid (1978) 1.32
Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology (2010) 1.27
Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec (1997) 1.25
Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis (1975) 1.24
Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin Nephrol (1984) 1.24
Active surveillance for Vibrio cholerae O1 and vibriophages in sewage water as a potential tool to predict cholera outbreaks. J Clin Microbiol (1996) 1.22
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J (2008) 1.22
Etiologic agents in acute vs persistent diarrhea in children under three years of age in peri-urban Lima, Perú. Acta Paediatr Suppl (1992) 1.22
Natural history of infection with Bartonella bacilliformis in a nonendemic population. J Infect Dis (2000) 1.22
Epidemiology of Echinococcus granulosus infection in the central Peruvian Andes. Bull World Health Organ (1997) 1.21
Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board). Am J Trop Med Hyg (1994) 1.20
Nothing's simple about malnutrition: complexities raised by epidemic neuropathy in Cuba. Am J Clin Nutr (1996) 1.19
Boiling of drinking-water: can a fuel-scarce community afford it? Bull World Health Organ (1985) 1.18
Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17
Combined human and porcine mass chemotherapy for the control of T. solium. Am J Trop Med Hyg (2006) 1.17
Single dose piperazine therapy for Ascaris lumbricoides: an unsuccessful method of promoting growth. Am J Clin Nutr (1981) 1.15
Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization. J Infect Dis (1976) 1.15
Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. Am J Epidemiol (1992) 1.15
Basic epidemiology of tuberculosis in Peru: a prevalence study of tuberculin sensitivity in a Pueblo joven. Am J Trop Med Hyg (1992) 1.14
18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol (2000) 1.14